Basic Information
SPIRIDON TABLETS 100MG
TABLET
Regulatory Information
SIN16709P
February 23, 2023
Prescription Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XC03DA01
Company Information
ORION PHARMA (SG) PTE. LTD.
ORION PHARMA (SG) PTE. LTD.
Active Ingredients
Strength: 100.0mg
Detailed Information
Contraindications
**4.3 Contraindications** Spironolactone is contraindicated in adults and children in the following cases: - acute renal insufficiency, significant renal compromise, anuria - Addison’s disease - hyperkalaemia - hypersensitivity to spironolactone - concomitant use of eplerenone. Spironolactone is contraindicated in children with moderate to severe renal insufficiency.
Indication Information
**4.1 Therapeutic indications** Spironolactone is indicated for the following: - Congestive cardiac failure - Hepatic cirrhosis with ascites and oedema - Malignant ascites - Nephrotic syndrome - Diagnosis and treatment of primary aldosteronism. Children should only be treated under guidance of a paediatrician. There is limited paediatric data available (see section 5.1 and 5.2 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).